Randomized trial to determine most effective, least toxic treatment for babies with SCID

(Children's Hospital Los Angeles) Investigators plan to determine the lowest dose of chemotherapy needed for babies with severe combined immunodeficiency undergoing bone marrow transplant. The goal is to restore the immune system safely and effectively with less toxicity than the higher dose regimens currently in use.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news